Proteus Digital Health IPO

Proteus Digital Health is a biotechnology company focused on creating a new category of pharmaceuticals: Digital Medicines, which include drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems.

Register for Details

For more details on financing and valuation of private companies similar to Proteus Digital Health before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Proteus Digital Health

To invest in Proteus Digital Health pre-IPO

Can you invest in Proteus Digital Health pre-IPO?

You can no longer invest in Proteus Digital Health with Forge. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Proteus Digital Health before it goes public?

You can no longer sell shares of Proteus Digital Health on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Proteus Digital Health shares?

Forge can no longer determine the value of Proteus Digital Health shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Proteus Digital Health a publicly traded company?

Proteus Digital Health became a public company following its M&A on 08/20/2020 and is now a publicly traded company.

To learn more about Proteus Digital Health potential IPO

Will Proteus Digital Health go IPO?

Proteus Digital Health became a public company following its M&A on 08/20/2020.

What is Proteus Digital Health’s IPO price?

The IPO price of Proteus Digital Health is not currently available.

When was Proteus Digital Health founded?

Proteus Digital Health was founded in 2001.

What is Proteus Digital Health funding to date?

Proteus Digital Health has raised $397.36MM to date.

Who are Proteus Digital Health’s major investors?

Kaiser Permanente Ventures
Sailing Capital
Oracle
Ventech
The Carlyle Group
Otsuka Pharmaceutical

Proteus Digital Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
04/15/2016 Series H $50MM $xx.xx $163.79B Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
3,164,557
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
07/29/2014 Series G $172MM $xx.xx $120B Orbimed & Sailing Capital
Price per Share
$xx.xx
Shares Outstanding
13,089,802
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Orbimed & Sailing Capital
05/02/2013 Series F $62.5MM $xx.xx $42.67B Novartis Venture Fund, On Semiconductor, Oracle, Otsuka Pharmaceutical, Sino Portfolio, Sutter Health Master Trust
Price per Share
$xx.xx
Shares Outstanding
10,775,862
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Novartis Venture Fund, On Semiconductor, Oracle, Otsuka Pharmaceutical, Sino Portfolio, Sutter Health Master Trust
12/26/2009 Series E $35MM $xx.xx $31.55B Adams Street Partners, Ew Healthcare Partners, Frazier Healthcare Partners, Novartis Venture Fund, Spring Ridge Ventures, The Carlyle Group
Price per Share
$xx.xx
Shares Outstanding
6,034,483
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Ew Healthcare Partners, Frazier Healthcare Partners, Novartis Venture Fund, Spring Ridge Ventures, The Carlyle Group
10/15/2008 Series D $32.05MM $xx.xx $26.03B Adams Street Partners, Ew Healthcare Partners, Itochu Technology Ventures, Kaiser Permanente Ventures, Medtronic, Others
Price per Share
$xx.xx
Shares Outstanding
5,828,173
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Ew Healthcare Partners, Itochu Technology Ventures, Kaiser Permanente Ventures, Medtronic, Others
08/15/2008 Series C $34.02MM $xx.xx $8.26B Adams Street Partners, Affinity Capital Management, Ew Heathcare Partners, Pacesetter Capital, Spring Ridge Ventures, The Carlyle Group
Price per Share
$xx.xx
Shares Outstanding
17,011,801
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Affinity Capital Management, Ew Heathcare Partners, Pacesetter Capital, Spring Ridge Ventures, The Carlyle Group
06/23/2004 Series B $11.03MM $xx.xx $1.67B Adam Street Partners, Asset Management Ventures, Fletcher Spaght Ventures, Kaiser Permanente Ventures, Others, Spring Ridge Ventures
Price per Share
$xx.xx
Shares Outstanding
12,255,556
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Asset Management Ventures, Fletcher Spaght Ventures, Kaiser Permanente Ventures, Others, Spring Ridge Ventures
12/16/2003 Series A $750,000.00 $xx.xx $300MM Asset Management Ventures & Spring Ridge Ventures
Price per Share
$xx.xx
Shares Outstanding
1,500,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Asset Management Ventures & Spring Ridge Ventures
Updated on: Nov 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.